FDA approves a clinical trial to test the effectiveness of new brain sensor array

FHS
June 19, 2024
5:51 pm

The Federal Drug Administration approved a clinical trial to test the effectiveness of an electronic grid that records brain activity during surgery, developed by engineers at the University of California San Diego.

J&J’s Tremfya fails giant cell arteritis study, where Roche and AbbVie have succeeded

Johnson & Johnson’s streak of trial wins for its blockbuster drug Tremfya has come to an end. The blockbuster drug failed in a Phase 2

June 26, 2024

Eye Drops for Presbyopia Win FDA Approval

The FDA approved pilocarpine hydrochloride ophthalmic solution (Qlosi) for adults with presbyopia, according to a statement from Orasis Pharmaceuticals. The approval allows for daily or

October 19, 2023

Spexis announces sale of preclinical antibiotics program to Basilea – Biotech Investments

Spexis AG / Key word(s): Disposal 15-Jan-2024 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely

January 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.